Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02058329 · ClinicalTrials.gov registry record · NA

A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications

A NA study, sponsored by Northwell Health.

Terminated
Registry status
NA
Development phase
18
Enrollment target

NCT02058329: Clinical Trial NA study, sponsored by Northwell Health.

NCT02058329 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02058329, a NA study, was terminated before completion, sponsored by Northwell Health.

TERMINATED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

The overall goal of the project is to reduce the incidence of post hip fracture morbidity and mortality by conducting geriatric fellow periodic home visits.The assessment will be multidisciplinary and will include assessments of functional status, depression, environmental risks and medical conditions. This group will be compared against a group followed by the usual standard of care post hip fracture.

Primary Outcome

geriatric depression screen, FIM score, medication reconciliation

Interventions

  • OTHER Home Visit

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2008-11
Est. Completion 2011-02
Phase NA
Northwell Health

370 total trials

Why NCT02058329 stopped before completion

NCT02058329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Home Visit is the first listed.

NCT02058329 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02058329 about?

NCT02058329 is a clinical study titled "A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications". The overall goal of the project is to reduce the incidence of post hip fracture morbidity and mortality by conducting geriatric fellow periodic home visits.The assessment will be multidisciplinary and will include assessments of functional status, depression, environmental risks and medical conditio...

What is the current status of trial NCT02058329?

This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2008-11. Estimated completion is 2011-02.

What interventions are being tested in trial NCT02058329?

The interventions under investigation include: Home Visit (OTHER).

Who is sponsoring clinical trial NCT02058329?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02058329's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02058329, the US trial registry maintained by the National Library of Medicine. NCT02058329 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.